Recombinant interferon alpha-2a in the treatment of classic Kaposi's sarcoma

dc.contributor.authorArica M.
dc.contributor.authorArslan A.
dc.contributor.authorMevlitoglu I.
dc.contributor.authorAytekin S.
dc.contributor.authorDerici M.
dc.date.accessioned2024-04-24T17:58:55Z
dc.date.available2024-04-24T17:58:55Z
dc.date.issued1996
dc.departmentDicle Üniversitesien_US
dc.description.abstractObservations. A case of classic Kaposi's Sarcoma (AIDS non related) in a 51-year-old man is presented. He was treated with recombinant interferon alpha-2a (6 million units/day) three times per week intramuscularly for 3 months. All lesions were completely resolved after treatment.en_US
dc.identifier.endpage49en_US
dc.identifier.issn1019-214X
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-0029827442en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage47en_US
dc.identifier.urihttps://hdl.handle.net/11468/24154
dc.identifier.volume30en_US
dc.indekslendigikaynakScopus
dc.language.isotren_US
dc.relation.ispartofTurkderm Deri Hastaliklari ve Frengi Arsivien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectInterferonen_US
dc.subjectKaposi's Sarcomaen_US
dc.titleRecombinant interferon alpha-2a in the treatment of classic Kaposi's sarcomaen_US
dc.title.alternativeKLASIK KAPOSI SARKOMUNUN REKOMBINANT INTERFERON ALFA 2A ILE TEDAVISIen_US
dc.typeArticleen_US

Dosyalar